An estimated 150 million UTIs occur annually on a global basis, accounting for direct health care costs exceeding 6 billion dollars and making UTIs a very significant public health burden. This program project proposes studies that will improve our understanding of the epidemiology, microbial ecology, molecular pathogenesis and prevention of UTIs. The objectives of the project will be met through the development of a multidisciplinary research team that will collaborate to carry out four interrelated projects. Project 1 will undertake a double-blind placebo-controlled trial to determine whether a Lactobacillus crispatis vaginal probiotic will reduce the incidence of recurrent UTIs in women. The trial will also study adherence of the probiotic strain to vaginal epithelial cells from the subjects and will thus provide insight into the host and microbial mechanisms involved. Project 2 will address the hypothesis that cell surface glycosphingolipids in the bladder and vaginal epithelium are structurally organized into pleotrophic plasma membrane assemblies called caveolae and that caveolae participate in the initial epithelial response to attachment and uptake of uropathogenic e. coil Project 3 will employ two novel technologies that were developed during the previous funding period, namely high density microarrays and whole genome mutation scanning to characterize on a genomic level the molecular adaptation that uropathogenic E. coil strains undergo in the course of recurrent UTIs and in shifting from an asymptomatic to symptomatic infection. The project will also define how such adaptive evolution affects the ability of uropathogens to bind and invade epithelial cells, induce inflammation and resist phagocytosis. In Project 4, the association of host susceptibility to recurrent cystitis or pyelonephritis with known or novel mutations in specifically selected candidate host genes will be examined. The candidate genes to be studied are toll-like receptors (TLR2, TLR4, and TLR6), chemokine receptors (CXCRI and CXCR2), and interferon y receptors (IFN-yR1 and IFN-yR2). A laboratory core will provide microbiological studies, primary bladder and vaginal epithelial cells, characterization of urovirulence genes, bacterial adherence assays and other resources to the projects. An Administrative/Biostatistical Core will coordinate the overall project and provide biostatistical expertise to all investigators. The proposed studies will result in an improved understanding of pathogenetic mechanisms in UTIs and will result in new approaches to prevention of UTIs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK053369-10
Application #
7279913
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M1))
Program Officer
Mullins, Christopher V
Project Start
1998-02-24
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2007
Total Cost
$1,178,013
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Steigedal, Magnus; Marstad, Anne; Haug, Markus et al. (2014) Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J Immunol 193:6081-9
Stapleton, Ann E (2013) Cranberry-containing products are associated with a protective effect against urinary tract infections. Evid Based Med 18:110-1
Hooton, Thomas M; Roberts, Pacita L; Cox, Marsha E et al. (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369:1883-91
Bateman, Stacey L; Stapleton, Ann E; Stamm, Walter E et al. (2013) The type 1 pili regulator gene fimX and pathogenicity island PAI-X as molecular markers of uropathogenic Escherichia coli. Microbiology 159:1606-17
Stapleton, Ann E; Dziura, James; Hooton, Thomas M et al. (2012) Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 87:143-50
Chaturvedi, Kaveri S; Hung, Chia S; Crowley, Jan R et al. (2012) The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat Chem Biol 8:731-6
Hooton, Thomas M; Roberts, Pacita L; Stapleton, Ann E (2012) Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA 307:583-9
Spurbeck, Rachel R; Dinh Jr, Paul C; Walk, Seth T et al. (2012) Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun 80:4115-22
Vigil, Patrick D; Stapleton, Ann E; Johnson, James R et al. (2011) Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio 2:e00066-11
Spurbeck, Rachel R; Stapleton, Ann E; Johnson, James R et al. (2011) Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 79:4753-63

Showing the most recent 10 out of 50 publications